DE602004014974D1 - Verwendung von zusammensetzungen mit oleansäure und ursolsäure zur herstellung eines medikaments zur behandlung von überempfindlichkeit und hyperreaktivität - Google Patents

Verwendung von zusammensetzungen mit oleansäure und ursolsäure zur herstellung eines medikaments zur behandlung von überempfindlichkeit und hyperreaktivität

Info

Publication number
DE602004014974D1
DE602004014974D1 DE602004014974T DE602004014974T DE602004014974D1 DE 602004014974 D1 DE602004014974 D1 DE 602004014974D1 DE 602004014974 T DE602004014974 T DE 602004014974T DE 602004014974 T DE602004014974 T DE 602004014974T DE 602004014974 D1 DE602004014974 D1 DE 602004014974D1
Authority
DE
Germany
Prior art keywords
acid
hyperreactivity
medicament
preparation
composites
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602004014974T
Other languages
English (en)
Inventor
Frederick W Cain
Wiro Stam
Ulrike Schmid
Geoff Collins
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lipid Nutrition BV
Original Assignee
Lipid Nutrition BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lipid Nutrition BV filed Critical Lipid Nutrition BV
Publication of DE602004014974D1 publication Critical patent/DE602004014974D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Polymers & Plastics (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE602004014974T 2003-12-19 2004-12-17 Verwendung von zusammensetzungen mit oleansäure und ursolsäure zur herstellung eines medikaments zur behandlung von überempfindlichkeit und hyperreaktivität Active DE602004014974D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03258087 2003-12-19
PCT/GB2004/005453 WO2005058302A1 (en) 2003-12-19 2004-12-17 Use of compositions comprising oleanic acid and ursolic acid for the preparation of a medicament for the treatment of hypersensitivity and hyperreactivity

Publications (1)

Publication Number Publication Date
DE602004014974D1 true DE602004014974D1 (de) 2008-08-21

Family

ID=34684630

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004014974T Active DE602004014974D1 (de) 2003-12-19 2004-12-17 Verwendung von zusammensetzungen mit oleansäure und ursolsäure zur herstellung eines medikaments zur behandlung von überempfindlichkeit und hyperreaktivität

Country Status (9)

Country Link
US (1) US20110229563A1 (de)
EP (1) EP1694320B1 (de)
JP (1) JP2007514727A (de)
CN (1) CN1893937B (de)
AT (1) ATE400262T1 (de)
DE (1) DE602004014974D1 (de)
ES (1) ES2311177T3 (de)
PL (1) PL1694320T3 (de)
WO (1) WO2005058302A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20170049623A (ko) * 2010-11-22 2017-05-10 피닉스 바이오테크놀러지 인코포레이티드. 네리움 종 또는 테베티아 종의 추출물로 신경학적 병태를 치료하는 방법
ES2925071T3 (es) 2013-02-08 2022-10-13 Gen Mills Inc Productos alimentarios reducidos en sodio
KR101645963B1 (ko) * 2014-05-13 2016-08-08 주식회사한국야쿠르트 사과박(apple pomace)으로부터 우르솔릭산을 고효율로 추출하는 방법 및 그 방법에 의해 추출된 우르솔릭산을 유효성분으로 함유하는 식품조성물
CN104610417B (zh) * 2015-02-16 2016-05-11 白心亮 一种从山楂中提取熊果酸和齐墩果酸的方法
RU2758376C2 (ru) * 2017-09-14 2021-10-28 Феникс Байотекнолоджи, Инк. Способ и улучшенная нейропротекторная композиция для лечения неврологических патологических состояний
JP7276745B2 (ja) * 2019-06-14 2023-05-18 地方独立行政法人青森県産業技術センター リンゴ由来トリテルペノイド含有組成物製造方法、ウルソール酸製造方法、およびオレアノール酸製造方法
CN112704663B (zh) * 2020-12-18 2022-07-19 吉林农业科技学院 一种枇杷叶熊果酸乳膏的制备方法
CN114129572B (zh) * 2021-12-16 2023-04-07 南开大学 一种协同抑制汉防己甲素诱导的药源性肝损伤的药物组合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03287530A (ja) * 1990-03-31 1991-12-18 Snow Brand Milk Prod Co Ltd 免疫抑制剤
JPH1112178A (ja) * 1997-06-23 1999-01-19 Dainippon Pharmaceut Co Ltd オレアノール酸系抗掻痒剤
DE60114708T2 (de) * 2000-06-05 2006-07-20 Loders Croklaan B.V. Ursolsäure und Oleanolsäure enthaltende Mischungen
DE60204078T2 (de) * 2001-04-09 2006-01-26 Loders Croklaan B.V. Konzentrat von Triterpenen
JP5081354B2 (ja) * 2001-11-07 2012-11-28 株式会社ナリス化粧品 ＩｇＥ産生抑制剤

Also Published As

Publication number Publication date
WO2005058302A1 (en) 2005-06-30
EP1694320A1 (de) 2006-08-30
PL1694320T3 (pl) 2008-11-28
JP2007514727A (ja) 2007-06-07
EP1694320B1 (de) 2008-07-09
ATE400262T1 (de) 2008-07-15
CN1893937A (zh) 2007-01-10
ES2311177T3 (es) 2009-02-01
CN1893937B (zh) 2011-01-12
US20110229563A1 (en) 2011-09-22

Similar Documents

Publication Publication Date Title
DE602005019319D1 (de) Zusammensetzungen mit ornithin und phenylacetat oder phenylbutyrat zur behandlung von hepatischer enzephalopathie
DE602004012745D1 (de) Synergistische zusammensetzung zur behandlung von diabetes mellitus
DE60118723D1 (de) Verwendung von azetogenischen hydrogenotrophischen stämmen zur vorbeugung und behandlung von verdauungskrankheiten
AR049955A1 (es) Composiciones y metodos para el tratamiento de trastornos metabolicos
DE60026152D1 (de) Verwendung von stearidonsäure zur herstellung eines arzneimittels für die behandlung oder vorbeugung von krebs
HUP0301518A2 (hu) Légzési rendellenességek kezelésére alkalmas száraz porkészítmény és eljárás az előállítására
IS8395A (is) Fjölvasýklískar karboxýlsýrur og asýlsúlfónamíð sem hindrar á lifrabólgu C eftirmyndun
DE602004014974D1 (de) Verwendung von zusammensetzungen mit oleansäure und ursolsäure zur herstellung eines medikaments zur behandlung von überempfindlichkeit und hyperreaktivität
ZA202210079B (en) Compositions and methods for treating or preventing inflammatory diseases including diabetes mellitus 10 type i and type ii and thyroid diseases
DE602004014275D1 (de) Zusammensetzung zur behandlung und/oder vorbeugung von insulinresistenz
Alaghehmad et al. Effect of 0.12% chlorhexidine and zinc nanoparticles on the microshear bond strength of dentin with a fifth-generation adhesive
ATE547120T1 (de) VERFAHREN ZUM EINKAPSELN VON ORAL AUFGENOMMENEN MATERIALIEN ZUR VERÄNDERUNG DES VERDAUUNGSORTES; DES WIRKORTES ODER DER STABILITÄTß
DE602004005455D1 (de) Verfahren zur behandlung oder prävention von chronischen wunden und komplette nahrungszusammensetzung mit glycin und/oder leucin zur verwendung darin
DE602006020838D1 (de) Medikamente zur prävention oder behandlung von herzversagen mit einem anticholinergikum
DE60206280D1 (de) Verwendung von extrakten aus ginkgo biloba zur herstellung eines medikaments zur behandlung von sarcopenia
DE602004012984D1 (de) Verwendung eines lupinkonglutins für die behandlung von diabetes typ ii
WO2006128179A3 (en) Use of matrilin-1 for the treatment of angiogenesis related diseases
PH12021551011A1 (en) Compositions and methods for treating transient biofilms
ATE386513T1 (de) Verwendung von angelicin und seiner strukturellen analoga zur behandlung von thalassämie
DE69930624D1 (de) Arzneimittel für hinterstrangataxie und zusammensetzung zur behandlung von hinterstrangataxie
DE69424679D1 (de) Zusammensetzung zur behandlung oder vorbeugung von herpes
WO2009015279A3 (en) Agents and methods for inhibition of airway hyperresponsiveness
DE602004016292D1 (de) Verwendung einer zusammensetzung mit vitamin k1-oxid oder einem derivat daraus zur behandlung und/oder vorbeugung von hautverletzungen bei säugern
WO2006010127A3 (en) Therapeutic compound and treatments
ATE468130T1 (de) Inhibitoren der kostimulation via ox40 und deren verwendung gegen eine von virusen induzierten immunpathologie

Legal Events

Date Code Title Description
8364 No opposition during term of opposition